GLP-1 Developer Kailera, Proteomics Firm Alamar File for IPO

GLP-1 developer Kailera, proteomics firm Alamar file for IPO

Kailera Therapeutics (KLRA), a weight loss drug developer, and Alamar Biosciences (ALMR), a commercial-stage proteomics company, filed for their IPOs. Read more here.

Kailera Therapeutics files for US IPO - Regional Media News

March 27 (Reuters) - Kailera Therapeutics filed for a U.S. initial public offering on Friday, becoming the latest biotech company looking to tap investor appetite as listings in the space gather momentum. U.S. companies have pushed on with their IPO plans even as the conflict in the Middle East threatens to roil the risk-on appetite in equities. Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut last month, giv…